N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide

C201H198N18O18 — CID 157349015

IUPACN-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
SMILESCC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1
InChIInChI=1S/C35H33N3O3.C34H37N3O3.C34H31N3O3.C33H29N3O3.C33H35N3O3.C32H33N3O3/c1-25(2)41-31-17-13-27(14-18-31)22-34(39)38-35-32(21-26-9-5-3-6-10-26)37-33(23-36-35)29-15-19-30(20-16-29)40-24-28-11-7-4-8-12-28;1-24(2)40-30-16-12-26(13-17-30)21-33(38)37-34-31(20-25-8-6-7-9-25)36-32(22-35-34)28-14-18-29(19-15-28)39-23-27-10-4-3-5-11-27;1-2-39-29-17-13-26(14-18-29)22-33(38)37-34-31(21-25-9-5-3-6-10-25)36-32(23-35-34)28-15-19-30(20-16-28)40-24-27-11-7-4-8-12-27;1-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-4-2-5-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-6-3-7-11-26;1-2-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-6-7-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-4-3-5-11-26;1-37-27-15-11-24(12-16-27)20-31(36)35-32-29(19-23-7-5-6-8-23)34-30(21-33-32)26-13-17-28(18-14-26)38-22-25-9-3-2-4-10-25/h3-20,23,25H,21-22,24H2,1-2H3,(H,36,38,39);3-5,10-19,22,24-25H,6-9,20-21,23H2,1-2H3,(H,35,37,38);3-20,23H,2,21-22,24H2,1H3,(H,35,37,38);2-19,22H,20-21,23H2,1H3,(H,34,36,37);3-5,10-19,22,24H,2,6-9,20-21,23H2,1H3,(H,34,36,37);2-4,9-18,21,23H,5-8,19-20,22H2,1H3,(H,33,35,36)
InChIKeyBHHQPZGUZYFSPC-UHFFFAOYSA-N
MW3153.90 g/mol
LogP41.78
Rot. Bonds64

About N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide

N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide (PubChem CID 157349015) has the molecular formula C201H198N18O18 and a molecular weight of 3153.90 g/mol. Its IUPAC name is N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide.

Molecular Properties

Compound NameN-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
PubChem CID157349015
Molecular FormulaC201H198N18O18
Molecular Weight3153.90 g/mol
Exact Mass3151.51
IUPAC NameN-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
SMILESCC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1
InChIInChI=1S/C35H33N3O3.C34H37N3O3.C34H31N3O3.C33H29N3O3.C33H35N3O3.C32H33N3O3/c1-25(2)41-31-17-13-27(14-18-31)22-34(39)38-35-32(21-26-9-5-3-6-10-26)37-33(23-36-35)29-15-19-30(20-16-29)40-24-28-11-7-4-8-12-28;1-24(2)40-30-16-12-26(13-17-30)21-33(38)37-34-31(20-25-8-6-7-9-25)36-32(22-35-34)28-14-18-29(19-15-28)39-23-27-10-4-3-5-11-27;1-2-39-29-17-13-26(14-18-29)22-33(38)37-34-31(21-25-9-5-3-6-10-25)36-32(23-35-34)28-15-19-30(20-16-28)40-24-27-11-7-4-8-12-27;1-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-4-2-5-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-6-3-7-11-26;1-2-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-6-7-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-4-3-5-11-26;1-37-27-15-11-24(12-16-27)20-31(36)35-32-29(19-23-7-5-6-8-23)34-30(21-33-32)26-13-17-28(18-14-26)38-22-25-9-3-2-4-10-25/h3-20,23,25H,21-22,24H2,1-2H3,(H,36,38,39);3-5,10-19,22,24-25H,6-9,20-21,23H2,1-2H3,(H,35,37,38);3-20,23H,2,21-22,24H2,1H3,(H,35,37,38);2-19,22H,20-21,23H2,1H3,(H,34,36,37);3-5,10-19,22,24H,2,6-9,20-21,23H2,1H3,(H,34,36,37);2-4,9-18,21,23H,5-8,19-20,22H2,1H3,(H,33,35,36)
InChIKeyBHHQPZGUZYFSPC-UHFFFAOYSA-N
XLogP41.78
TPSA440.04 Ų
H-Bond Donors6
H-Bond Acceptors30
Rotatable Bonds64
Heavy Atoms237
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003153.90
LogP ≤ 541.78
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1030

Analyze N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[5-(2,2-difluoro-7-methyl-3H-1,4-benzodioxin-6-yl)pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)pyrazin-2-yl]-2,6-difluorobenzamide;N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)pyrazin-2-yl]-2-methylpropanamide;N-[5-(2,2-difluoro-7-methyl-3H-1,4-benzodioxin-6-yl)-2-pyridinyl]-2,6-difluorobenzamide;N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)-2-pyridinyl]-2,6-difluorobenzamide;N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)-2-pyridinyl]-2-methylpropanamide
CID 157138371
2-Amino-5-[2-(dimethylamino)-4-pyridinyl]-5-[4-(1-fluoroethoxy)-3-methylphenyl]-3-methylimidazol-4-one;2-amino-5-[5-(dimethylamino)-3-pyridinyl]-5-[4-(1-fluoroethoxy)-3-methylphenyl]-3-methylimidazol-4-one;2-amino-5-[4-(1-fluoroethoxy)-3-methylphenyl]-5-(2-methoxy-4-pyridinyl)-3-methylimidazol-4-one;2-amino-5-[4-(1-fluoroethoxy)-3-methylphenyl]-3-methyl-5-(2-propan-2-yl-4-pyridinyl)imidazol-4-one;2-amino-5-[4-(1-fluoroethoxy)-3-methylphenyl]-3-methyl-5-[2-(trifluoromethyl)-4-pyridinyl]imidazol-4-one
CID 157179165
bis(N-[5-(2,2-difluoro-7-methyl-3H-1,4-benzodioxin-6-yl)pyrazin-2-yl]-2,6-difluorobenzamide);bis(N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)pyrazin-2-yl]-2,6-difluorobenzamide);bis(N-[5-(2,2-difluoro-7-methyl-3H-1,4-benzodioxin-6-yl)-2-pyridinyl]-2,6-difluorobenzamide);N-[5-(3,3-difluoro-7-methyl-2H-1,4-benzodioxin-6-yl)-2-pyridinyl]-2,6-difluorobenzamide
CID 161487219
N-[3-benzyl-5-(4-ethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide
CID 46853648
N-[3-(cyclohexylmethyl)-5-(4-ethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide
CID 46853649
N-[3-(cyclopentylmethyl)-5-(4-ethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide
CID 46853670
N-[3-(cyclopentylmethyl)-5-(4-propan-2-yloxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
CID 46853671
N-[3-(cyclohexylmethyl)-5-(4-propan-2-yloxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
CID 46853672
N-[3-benzyl-5-(4-propan-2-yloxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide
CID 46853673
N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-phenylmethoxyphenyl)acetamide
CID 46853694
N-[3-(cyclohexylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-phenylmethoxyphenyl)acetamide
CID 46853695
N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-phenylmethoxyphenyl)acetamide
CID 46853696

Frequently Asked Questions

What is the IUPAC name of N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide?
The IUPAC name of N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide (CID 157349015) is N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide.
What is the SMILES notation for N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide?
The canonical SMILES for N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide is CC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CC(C)Oc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.CCOc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2CC2CCCC2)cc1.COc1ccc(CC(=O)Nc2ncc(-c3ccc(OCc4ccccc4)cc3)nc2Cc2ccccc2)cc1.
What is the InChIKey of N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide?
The InChIKey is BHHQPZGUZYFSPC-UHFFFAOYSA-N. The full InChI is InChI=1S/C35H33N3O3.C34H37N3O3.C34H31N3O3.C33H29N3O3.C33H35N3O3.C32H33N3O3/c1-25(2)41-31-17-13-27(14-18-31)22-34(39)38-35-32(21-26-9-5-3-6-10-26)37-33(23-36-35)29-15-19-30(20-16-29)40-24-28-11-7-4-8-12-28;1-24(2)40-30-16-12-26(13-17-30)21-33(38)37-34-31(20-25-8-6-7-9-25)36-32(22-35-34)28-14-18-29(19-15-28)39-23-27-10-4-3-5-11-27;1-2-39-29-17-13-26(14-18-29)22-33(38)37-34-31(21-25-9-5-3-6-10-25)36-32(23-35-34)28-15-19-30(20-16-28)40-24-27-11-7-4-8-12-27;1-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-4-2-5-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-6-3-7-11-26;1-2-38-28-16-12-25(13-17-28)21-32(37)36-33-30(20-24-8-6-7-9-24)35-31(22-34-33)27-14-18-29(19-15-27)39-23-26-10-4-3-5-11-26;1-37-27-15-11-24(12-16-27)20-31(36)35-32-29(19-23-7-5-6-8-23)34-30(21-33-32)26-13-17-28(18-14-26)38-22-25-9-3-2-4-10-25/h3-20,23,25H,21-22,24H2,1-2H3,(H,36,38,39);3-5,10-19,22,24-25H,6-9,20-21,23H2,1-2H3,(H,35,37,38);3-20,23H,2,21-22,24H2,1H3,(H,35,37,38);2-19,22H,20-21,23H2,1H3,(H,34,36,37);3-5,10-19,22,24H,2,6-9,20-21,23H2,1H3,(H,34,36,37);2-4,9-18,21,23H,5-8,19-20,22H2,1H3,(H,33,35,36).
What are the key properties of N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide?
N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide has a molecular weight of 3153.90 g/mol, XLogP of 41.78, 64 rotatable bonds, 6 hydrogen bond donors, and 30 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-benzyl-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-ethoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-methoxyphenyl)acetamide;N-[3-(cyclopentylmethyl)-5-(4-phenylmethoxyphenyl)pyrazin-2-yl]-2-(4-propan-2-yloxyphenyl)acetamide is sourced from PubChem (CID 157349015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).